Roche Confirms Pharma Appetite for Inflammatory Disease Treatments
Roche’s acquisition of the Irish biotech Inflazome is a vote of confidence for emerging inflammatory…
25/09/2020 - 4 minutes
Inflammatory Disease
€18M to Fund First-in-Class Systemic Sclerosis Drug
One of the largest biotech placements in the Nordic countries this year will accelerate the…
09/07/2020 - 2 minutes
Boost For Inflammatory Disease Biotech NodThera With €49M Series B
The UK-US biotech NodThera has raised €48.7M in Series B funding to progress its drug…
06/06/2020 - 3 minutes
Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III
A small molecule drug developed by the US company ChemoCentryx and its Swiss partner Vifor…
26/11/2019 - 3 minutes
Update: Abivax’s Ulcerative Colitis Drug Effective Long-Term
Update (21/10/2019): An extension of French biotech Abivax’s phase IIa trial shows its treatment for…
21/10/2019 - 2 minutes
French Biotech to Develop Septic Shock Therapy with €39M Series B
The French company Inotrem has raised €39M to fund an immunotherapy for septic shock, an…
12/09/2019 - 3 minutes
Swedish Ulcerative Colitis Treatment Makes Phase II Comeback
InDex Pharmaceuticals’ ulcerative colitis drug candidate has achieved positive phase IIb results, suggesting work to…
27/08/2019 - 2 minutes
This Biotech Uses Messenger RNA to Treat Lethal Lung Inflammation
Based close to Berlin, Germany, the biotech startup Pantherna Therapeutics is developing a messenger RNA…
02/08/2019 - 4 minutes
Atlantic Healthcare’s Inflammatory Bowel Disease RNA Drug Fails Phase III
Hopes of seeing an approved treatment for the inflammatory bowel condition pouchitis have been dashed…
01/08/2019 - 2 minutes
British Biotech Raises €11M to Market Personalized Medicine Test
The UK biotech PredictImmune has raised €11M (£10M) in a Series B fundraising round to…
31/07/2019 - 3 minutes
German Biotech Breath Therapeutics Acquired in Deal Worth up to €500M
The Italian company Zambon has acquired the German biotech Breath Therapeutics for up to €500M,…
25/07/2019 - 2 minutes
Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A
The Dutch biotech Citryll has raised €15M to develop antibodies that could fight autoimmune and…
04/07/2019 - 2 minutes
